Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Interest Expenses: 2009-2025

Historic Interest Expenses for Aytu Biopharma (AYTU) over the last 13 years, with Sep 2025 value amounting to $516,000.

  • Aytu Biopharma's Interest Expenses fell 48.09% to $516,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 32.39%. This contributed to the annual value of $3.7 million for FY2025, which is 26.80% down from last year.
  • According to the latest figures from Q3 2025, Aytu Biopharma's Interest Expenses is $516,000, which was down 29.32% from $730,000 recorded in Q2 2025.
  • Aytu Biopharma's 5-year Interest Expenses high stood at $1.3 million for Q3 2023, and its period low was $516,000 during Q3 2025.
  • Moreover, its 3-year median value for Interest Expenses was $1.1 million (2024), whereas its average is $1.0 million.
  • Data for Aytu Biopharma's Interest Expenses shows a maximum YoY tumbled of 48.09% (in 2025) over the last 5 years.
  • Aytu Biopharma's Interest Expenses (Quarterly) stood at $1.3 million in 2023, then fell by 14.77% to $1.1 million in 2024, then slumped by 48.09% to $516,000 in 2025.
  • Its last three reported values are $516,000 in Q3 2025, $730,000 for Q2 2025, and $900,000 during Q1 2025.